((4S,5R)-2-(4-(tert-butyl)-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dihydro-1H-imidazol-1-yl)(piperazin-1-yl)methanone

ID: ALA4544337

PubChem CID: 11548998

Max Phase: Preclinical

Molecular Formula: C32H36Cl2N4O2

Molecular Weight: 579.57

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Bioactivity Summary Target Summary Assay Summary

Names and Identifiers

Canonical SMILES: CCOc1cc(C(C)(C)C)ccc1C1=N[C@@H](c2ccc(Cl)cc2)[C@@H](c2ccc(Cl)cc2)N1C(=O)N1CCNCC1

Standard InChI: InChI=1S/C32H36Cl2N4O2/c1-5-40-27-20-23(32(2,3)4)10-15-26(27)30-36-28(21-6-11-24(33)12-7-21)29(22-8-13-25(34)14-9-22)38(30)31(39)37-18-16-35-17-19-37/h6-15,20,28-29,35H,5,16-19H2,1-4H3/t28-,29+/m0/s1

Standard InChI Key: FLVZHJXGYBGXDA-URLMMPGGSA-N

Molfile:

 
     RDKit          2D

 40 44  0  0  0  0  0  0  0  0999 V2000
   18.7698  -17.9633    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9952  -18.2134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9948  -19.0321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7701  -19.2870    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.2511  -18.6224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3321  -17.7341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4199  -16.9164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7560  -16.4314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0040  -16.7670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9198  -17.5882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5846  -18.0655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3332  -19.5172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5819  -19.1835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9172  -19.6634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0026  -20.4811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7584  -20.8166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4199  -20.3306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3387  -16.2826    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   15.3382  -20.9667    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   20.0683  -18.6198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4819  -19.3324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3025  -19.3310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7104  -18.6178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2959  -17.9045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4767  -17.9094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0267  -17.1820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8302  -17.0123    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.4759  -16.5704    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.3736  -17.6282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1740  -17.4612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4350  -16.6809    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.8851  -16.0673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0783  -16.2340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5317  -18.6150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9469  -19.3254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9420  -17.9018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3519  -18.6138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0700  -20.0447    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.4835  -20.7561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0715  -21.4642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  1  2  1  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
  2  6  1  1
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  3 12  1  1
  9 18  1  0
 15 19  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
  5 20  1  0
  1 26  1  0
 26 27  1  0
 26 28  2  0
 27 29  1  0
 27 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 23 34  1  0
 34 35  1  0
 34 36  1  0
 34 37  1  0
 21 38  1  0
 38 39  1  0
 39 40  1  0
M  END

Associated Targets(Human)

MDM2 Tchem Protein cereblon/E3 ubiquitin-protein ligase Mdm2 (233 Activities)

Discover Target: MDM2

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

RS4-11 (1012 Activities)

Explore this target

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Natural Product: No	Oral: No	Chemical Probe: No	Parenteral: No
Molecule Type: Unknown	Topical: No	First In Class: No	Black Box: No
Chirality: No	Availability: No	Prodrug: No

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 579.57	Molecular Weight (Monoisotopic): 578.2215	AlogP: 7.26	#Rotatable Bonds: 5
Polar Surface Area: 57.17	Molecular Species: NEUTRAL	HBA: 4	HBD: 1
#RO5 Violations: 2	HBA (Lipinski): 6	HBD (Lipinski): 1	#RO5 Violations (Lipinski): 2
CX Acidic pKa: ┄	CX Basic pKa: 7.82	CX LogP: 7.20	CX LogD: 6.64
Aromatic Rings: 3	Heavy Atoms: 40	QED Weighted: 0.35	Np Likeness Score: -0.32

References

1. Wang B, Wu S, Liu J, Yang K, Xie H, Tang W.. (2019) Development of selective small molecule MDM2 degraders based on nutlin., 176 [PMID:31128449] [10.1016/j.ejmech.2019.05.046]
2. Raboisson, Pierre P and 12 more authors. 2005-04-01 Structure-based design, synthesis, and biological evaluation of novel 1,4-diazepines as HDM2 antagonists. [PMID:15780621]
3. Schneekloth, Ashley R AR, Pucheault, Mathieu M, Tae, Hyun Seop HS and Crews, Craig M CM. 2008-11-15 Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics. [PMID:18752944]
4. Hayashi, Ryo R and 5 more authors. 2009-12-01 N-acylpolyamine inhibitors of HDM2 and HDMX binding to p53. [PMID:19880322]
5. Madden, Michael M and 5 more authors. 2011-03-01 Synthesis of cell-permeable stapled peptide dual inhibitors of the p53-Mdm2/Mdmx interactions via photoinduced cycloaddition. [PMID:21277201]
6. Ghosh, Pradip P, Zhang, Jiawei J, Shi, Zheng-Zheng ZZ and Li, King K. 2013-04-15 Synthesis and evaluation of an imidazole derivative-fluorescein conjugate. [PMID:23477941]
7. Zhao, Yujun Y and 12 more authors. 2013-07-11 A potent small-molecule inhibitor of the MDM2-p53 interaction (MI-888) achieved complete and durable tumor regression in mice. [PMID:23786219]
8. Blackburn, Tim J and 14 more authors. 2013-09-21 Diaryl- and triaryl-pyrrole derivatives: inhibitors of the MDM2-p53 and MDMX-p53 protein-protein interactions†Electronic supplementary information (ESI) available: Experimental details for compound synthesis, analytical data for all compounds and intermediates. Details for the biological evaluation. Further details for the modeling. Table of combustion analysis data. See DOI: 10.1039/c3md00161jClick here for additional data file. [PMID:24078862]
9. Li, Jin J and 14 more authors. 2014-06-15 Discovery of 1-arylpyrrolidone derivatives as potent p53-MDM2 inhibitors based on molecule fusing strategy. [PMID:24813735]
10. Zheng, Guang-hui GH and 7 more authors. 2014-06-23 Design, synthesis and in vitro and in vivo antitumour activity of 3-benzylideneindolin-2-one derivatives, a novel class of small-molecule inhibitors of the MDM2-p53 interaction. [PMID:24852275]
11. Rew, Yosup Y and 34 more authors. 2014-12-26 Discovery of AM-7209, a potent and selective 4-amidobenzoic acid inhibitor of the MDM2-p53 interaction. [PMID:25384157]
12. Zhao, Yujun Y, Aguilar, Angelo A, Bernard, Denzil D and Wang, Shaomeng S. 2015-02-12 Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatment. [PMID:25396320]
13. Aguilar, Angelo and 7 more authors. 2014-12-26 Design of chemically stable, potent, and efficacious MDM2 inhibitors that exploit the retro-mannich ring-opening-cyclization reaction mechanism in spiro-oxindoles. [PMID:25496041]
14. Neochoritis, Constantinos G and 8 more authors. 2015-12-15 2,30-Bis(10H-indole) heterocycles: New p53/MDM2/MDMX antagonists. [PMID:26584879]
15. Daniele, Simona S and 12 more authors. 2016-05-26 Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas. [PMID:27050782]
16. Aguilar, Angelo and 17 more authors. 2017-04-13 Discovery of 4-((3'R,4'S,5'R)-6″-Chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2″-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3″-indoline]-5'-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development. [PMID:28339198]
17. Giustiniano, Mariateresa M and 18 more authors. 2017-10-12 Computer-Aided Identification and Lead Optimization of Dual Murine Double Minute 2 and 4 Binders: Structure-Activity Relationship Studies and Pharmacological Activity. [PMID:28921985]
18. Merlino, Francesco F and 20 more authors. 2018-06-14 Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme. [PMID:29775303]
19. Niazi, Sarfaraj S, Purohit, Madhusudan M and Niazi, Javed H JH. 2018-10-05 Role of p53 circuitry in tumorigenesis: A brief review. [PMID:30199707]
20. Wang, Bo B and 5 more authors. 2019-08-15 Development of selective small molecule MDM2 degraders based on nutlin. [PMID:31128449]
21. Sang, Peng and 10 more authors. 2020-02-13 α-Helix-Mimicking Sulfono-γ-AApeptide Inhibitors for p53-MDM2/MDMX Protein-Protein Interactions. [PMID:31971801]

((4S,5R)-2-(4-(tert-butyl)-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dihydro-1H-imidazol-1-yl)(piperazin-1-yl)methanone

Names and Identifiers

Alternative Forms

Associated Targets(Human)

Molecule Features

Drug Indications

Mechanisms of Action

Biocomponents

Calculated Properties

References

Source